Myeloma UK – current focus and future directions
The role of blinatumomab in ALL
The progress of CLL research: towards targeted therapy
Does the use of the checkpoint inhibitor nivolumab affect the outcomes of transplant?
Carmelo Carlo Stella
What makes the British Society for Haematology (BSH) Annual Scientific Meeting unique?